The public release of highly advanced large language models, specifically OpenAI's Sol and Anthropic's Fable, has brought to light a significant void in governmental oversight regarding their safety protocols. These models, which possess capabilities that have previously caused concern at the White House, are now widely accessible, yet the precise methodologies employed by regulatory bodies to sanction their deployment remain largely undisclosed. This lack of transparency has ignited a vigorous debate among experts and industry stakeholders.
Unraveling the Enigma of AI Model Approvals
In July 2026, OpenAI officially launched its sophisticated Sol model to the general public, following a similar pattern seen with Anthropic's Fable. Fable, notably, had been temporarily restricted from public access due to its potent capabilities and questions surrounding its ownership, which had caused unease within the White House. Both models are considered to be at the forefront of AI development, raising questions about the rigorousness of their safety evaluations.
Mina Narayanan, a seasoned research analyst at Georgetown's Center for Security and Emerging Technology, voiced her concerns to TechCrunch, stating her lack of insight into the exact processes that led to these approvals. She noted Anthropic's claims of government dialogues and the implementation of robust defense mechanisms against potential 'jailbreak' attempts, but the specifics of these interactions with both Anthropic and OpenAI remain shrouded in mystery. Echoing this sentiment, Dean W. Ball, a former policy advisor in the Trump administration now affiliated with OpenAI, remarked in his newsletter last month that the criteria for obtaining licensing for such models are entirely unclear. Andy Konwinski, a co-founder of Databricks, Perplexity, and the Laude Institute, further emphasized the pervasive confusion within the industry, highlighting that even personnel at leading AI labs are unaware of the regulatory framework. He critically pointed out that this ambiguity raises fundamental questions about who truly holds the authority to make critical decisions and control access in the AI domain.
Despite being 18 months into the Trump administration, a coherent strategy for regulating frontier AI models has yet to materialize. Although an executive order was issued last month to outline a roadmap for evaluation, detailed specifics are still absent. A former senior advisor for AI in the White House, Sriram Krishnan, indicated to the Financial Times that there would be no AI equivalent of the FDA, suggesting a hands-off approach to regulation. Currently, the Department of Commerce's Center for AI Standards and Innovation appears to be spearheading efforts, with six cabinet agencies tasked to define a definitive process by early August. However, interim measures have been, at best, inconsistent.
OpenAI CEO Sam Altman confirmed engaging with high-ranking government officials, including Secretary of Commerce Howard Lutnick, Secretary of the Treasury Scott Bessent, and U.S. national cyber director Sean Cairncross. Yet, details regarding the expert teams that assessed the models and their evaluation methodologies remain undisclosed. OpenAI chose not to elaborate on the government's specific procedures when contacted by TechCrunch, instead directing attention to external evaluations performed by entities such as U.K. AISI, SecureBio, and Irregular, whose findings are summarized in the latest model's safety card. Prior to wider public release, OpenAI, like Anthropic, offered government officials and selected individuals a preview of the model. The selection criteria for these preview users, however, have not been disclosed. OpenAI acknowledged in a late June blog post that current government access processes for AI models are not ideal for the long term and expressed a commitment to collaboratively developing a more effective path forward.
The regulatory landscape is further complicated by the intricate relationship between AI companies and political figures. Reports of Altman's alleged offer of OpenAI equity to the administration's "Trump Accounts" and OpenAI president Greg Brockman's significant donations to Trump's political campaigns suggest potential influences on the government's regulatory stance towards models like Sol. This intertwining of business and politics makes it challenging for external observers to ascertain whether the seemingly lenient regulatory approach is entirely independent of these connections.
While a less restrictive regulatory environment might appeal to the industry, a system reliant on personal connections with administration officials breeds uncertainty and fosters perverse incentives. Konwinski expressed apprehension that genuine experts—spanning safety, alignment, interpretability research, and data science—are not adequately involved in the model release process. He champions an "open commons" approach, citing models like the FDA and NIH, where researchers, government, and private entities collaborate to achieve consensus on safety. The capitalist drive, which has long fueled AI innovation and was central to Elon Musk's legal challenge against OpenAI's corporate structure, mandates that companies quickly recoup training costs to maintain a competitive edge. Konwinski underscored that, irrespective of good intentions, companies are bound by clear legal and fiduciary duties.
Ball suggested that future progress would hinge on government-licensed third-party auditing organizations evaluating the safety approaches of frontier labs. Konwinski also supports new institutional models, such as focused research organizations, which could enable impartial experts from academia and non-profit sectors to access and assess frontier models. For the present, the veil of secrecy surrounding AI development persists. This secrecy, however, is likely to generate political friction for an industry that faces increasing skepticism from the American public. As Remzi Arpaci-Dusseau, a computer science professor at the University of Wisconsin-Madison, noted at the Open Frontier conference, there's a prevailing sense that responsible parties are not guiding these advancements. David Siegel, the computer scientist who founded Two Sigma, posed a cautionary scenario at the same event: a future where a select few firms dominate technology, government agencies covertly assess its suitability, and the general public and scientific community are denied access. He concluded that this scenario, far from being imaginary, might already be unfolding.
The current lack of clarity surrounding government approval processes for advanced AI models like OpenAI's Sol and Anthropic's Fable presents a significant challenge to public trust and accountability. The interplay between industry influence and regulatory oversight raises profound questions about transparency and fairness in a sector poised to reshape society. Moving forward, establishing a standardized, expert-driven, and transparent framework for evaluating AI safety will be crucial to fostering innovation responsibly and mitigating potential risks.
